Back to top

Image: Bigstock

Hi-Crush (HCLP) Beats Earnings and Revenue Estimates in Q3

Read MoreHide Full Article

Hi-Crush Partners LP delivered profit of $26.5 million or 29 cents per share in third-quarter 2018, down from $29.8 million or 32 cents in the year-ago quarter.

Barring one-time items, adjusted earnings came in at 36 cents, which beat the Zacks Consensus Estimate of 31 cents.

Revenues surged roughly 27.7% year over year to $214 million. The figure narrowly surpassed the Zacks Consensus Estimate of $212.4 million.

Hi-Crush Partners LP Price, Consensus and EPS Surprise

 

Hi-Crush Partners LP Price, Consensus and EPS Surprise | Hi-Crush Partners LP Quote

Total frac sand sold during third-quarter 2018 was 2,775,360 tons, up 13% year over year. Contribution margin per ton sold was up 23.4% year over year to $23.92. Volumes sold at the wellsite through PropStream and directly to E&Ps increased to 24% and 40% of total sales volumes, respectively.

Per the partnership, third-quarter results benefited from the increase in volumes sold through PropStream logistics services and sales directly to operators amid a challenging and rapidly evolving market scenario.  

Operational Update

On Aug 1, 2018, Hi-Crush closed the acquisition of FB Industries Inc. At the end of the third quarter, there were 69 legacy FB Industries silo systems in the field.

As of Sep 30, 2018, the partnership had 16 PropStream container systems in the Permian Basin and Marcellus/Utica plays. Also, 16 of the 52 container systems developed by PropX were currently in the field. Hi-Crush expects to deploy nearly 60 PropX container systems by the end of 2018, of which 20 will be ready for operation for customers. Moreover, the partnership will have 8 silo systems under lease arrangements in November. The partnership has several silo systems in inventory that are ready to be deployed and it continues to build more systems by year-end.
 
Financial Position

As of Sep 30, 2018, the partnership had $175.4 million in cash and $97.7 million in available capacity under its revolving credit facility. Hi-Crush had outstanding long-term debt of roughly $444 million as of Sep 30, compared with $194.5 million a year ago.

Distribution

On Oct 21, the partnership declared quarterly cash distribution of 22.5 cents per unit on all common units, down from the previous quarterly cash distribution of 75 cents per unit. The distribution will be paid on Nov 14 to unitholders of record as of Nov 1.

Outlook

Hi-Crush witnessed rapid change in market conditions in the frac sand sector during the quarter, which led to the declines in well completion activity and frac sand demand. The change also affected the market for Northern White pricing and volumes, which is expected to continue in the fourth quarter.

The partnership expects total sales volumes for the fourth quarter in the range of 2.3-2.5 million tons. Notably, total volumes sold in the fourth quarter are likely to be affected by continued weakness in completions activity along with typical seasonal slowdowns. The partnership expects completions activity to increase in 2019 along with improving demand and supply dynamics for frac sand.

Price Performance

Hi-Crush’s shares have lost 20.9% in the past year compared with the industry’s 6.4% decline.

 



Zacks Rank & Stocks to Consider

Hi-Crush currently carries a Zacks Rank #4 (Sell).

A few better-ranked stocks in the basic materials space are Methanex Corporation (MEOH - Free Report) , KMG Chemicals, Inc. and CF Industries Holdings, Inc. (CF - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Methanex has expected long-term earnings growth rate of 15%. Its shares have rallied 32.4% in the past year.

KMG Chemicals has expected long-term earnings growth rate of 28.5%. Its shares have rallied 35.8% in the past year.

CF Industries has expected long-term earnings growth rate of 6%. Its shares have gained 21.8% in a year.

3 Medical Stocks to Buy Now

The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.

So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.

See them today for free >>


Unique Zacks Analysis of Your Chosen Ticker


Pick one free report - opportunity may be withdrawn at any time


CF Industries Holdings, Inc. (CF) - $25 value - yours FREE >>

Methanex Corporation (MEOH) - $25 value - yours FREE >>

Published in